The BCY3/BCC 2017 survey on physicians' knowledge, attitudes and practice towards fertility and pregnancy-related issues in young breast cancer patients.

[1]  S. Linn,et al.  Stimulation of the ovaries in women with breast cancer undergoing fertility preservation: alternative versus standard stimulation protocols , 2019, Fertility and Sterility.

[2]  J. Cuzick,et al.  De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

[3]  S. Loibl,et al.  Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Premenopausal Patients With Early Breast Cancer: A Systematic Review and Meta-Analysis of Individual Patient-Level Data. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  M. Ignatiadis,et al.  Long-term Safety of Pregnancy Following Breast Cancer According to Estrogen Receptor Status. , 2018, Journal of the National Cancer Institute.

[5]  P. Neven,et al.  Axillary staging for breast cancer during pregnancy: feasibility and safety of sentinel lymph node biopsy , 2018, Breast Cancer Research and Treatment.

[6]  B. van Calster,et al.  Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: a 20-year international cohort study of 1170 patients. , 2018, The Lancet. Oncology.

[7]  M. Lambertini,et al.  How reliable are the available safety data on hormonal stimulation for fertility preservation in young women with newly diagnosed early breast cancer? , 2018, Breast Cancer Research and Treatment.

[8]  J. Bergh,et al.  Safety of fertility preservation in breast cancer patients in a register-based matched cohort study , 2017, Breast Cancer Research and Treatment.

[9]  K. Gelmon,et al.  ESO-ESMO 3rd international consensus guidelines for breast cancer in young women (BCY3). , 2017, Breast.

[10]  S. Linn,et al.  Stimulation of the ovaries in women with breast cancer undergoing fertility preservation: Alternative versus standard stimulation protocols; the study protocol of the STIM-trial. , 2017, Contemporary clinical trials.

[11]  PaganiOlivia,et al.  Oncology Physicians' Perspectives on Practices and Barriers to Fertility Preservation and the Feasibility of a Prospective Study of Pregnancy After Breast Cancer. , 2017 .

[12]  D. Adamson,et al.  GnRH agonist for protection against ovarian toxicity during chemotherapy for early breast cancer: the Anglo Celtic Group OPTION trial , 2017, Annals of Oncology.

[13]  K. Oktay,et al.  Current Success and Efficiency of Autologous Ovarian Transplantation: A Meta-Analysis , 2017, Reproductive Sciences.

[14]  F. Clatot,et al.  Controversies about fertility and pregnancy issues in young breast cancer patients: current state of the art , 2017, Current opinion in oncology.

[15]  P. Scaruffi,et al.  State of the art on oocyte cryopreservation in female cancer patients: A critical review of the literature. , 2017, Cancer treatment reviews.

[16]  P. Rochon,et al.  Association of the Timing of Pregnancy With Survival in Women With Breast Cancer , 2017, JAMA oncology.

[17]  G. Eslick,et al.  The prognosis of women diagnosed with breast cancer before, during and after pregnancy: a meta-analysis , 2016, Breast Cancer Research and Treatment.

[18]  V. Turan,et al.  Long-Term Safety of Letrozole and Gonadotropin Stimulation for Fertility Preservation in Women With Breast Cancer. , 2016, The Journal of clinical endocrinology and metabolism.

[19]  Alberto Revelli,et al.  Cancer and fertility preservation: international recommendations from an expert meeting , 2016, BMC Medicine.

[20]  L. Boni,et al.  Ovarian Suppression With Triptorelin During Adjuvant Breast Cancer Chemotherapy and Long-term Ovarian Function, Pregnancies, and Disease-Free Survival: A Randomized Clinical Trial. , 2015, JAMA.

[21]  S. Loibl,et al.  Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studies. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

[22]  L. Lagae,et al.  Pediatric Outcome after Maternal Cancer Diagnosed during Pregnancy. , 2015, The New England journal of medicine.

[23]  C. Denkert,et al.  Breast Cancer Diagnosed During Pregnancy: Adapting Recent Advances in Breast Cancer Care for Pregnant Patients. , 2015, JAMA oncology.

[24]  L. Newman,et al.  Breast Cancer in Young Women: Rare Disease or Public Health Problem? , 2015, JAMA oncology.

[25]  B. Pistilli,et al.  Pregnancy following breast cancer using assisted reproduction and its effect on long-term outcome. , 2015, European journal of cancer.

[26]  W. Wallace,et al.  Cancer treatment and gonadal function: experimental and established strategies for fertility preservation in children and young adults. , 2015, The lancet. Diabetes & endocrinology.

[27]  G. Bedoschi,et al.  Fertility Preservation Success Subsequent to Concurrent Aromatase Inhibitor Treatment and Ovarian Stimulation in Women With Breast Cancer. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  N. Biglia,et al.  Attitudes on fertility issues in breast cancer patients: an Italian survey , 2015, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[29]  R. Gelber,et al.  Pregnancy after breast cancer: Are young patients willing to participate in clinical studies? , 2015, Breast.

[30]  M. Lambertini,et al.  Targeted agents for cancer treatment during pregnancy. , 2015, Cancer treatment reviews.

[31]  J. Forbes,et al.  Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy. , 2015, The New England journal of medicine.

[32]  Y. Englert,et al.  Safety and usefulness of cryopreservation of ovarian tissue to preserve fertility: a 12-year retrospective analysis. , 2014, Human reproduction.

[33]  W. Wallace,et al.  Fertility preservation for girls and young women with cancer: population-based validation of criteria for ovarian tissue cryopreservation , 2014, The Lancet. Oncology.

[34]  S. Paluch-Shimon,et al.  Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies. , 2014, Fertility and sterility.

[35]  R. Tamimi,et al.  Prospective study of fertility concerns and preservation strategies in young women with breast cancer. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  H. Gómez,et al.  Attitudes of young patients with breast cancer toward fertility loss related to adjuvant systemic therapies. EORTC study 10002 BIG 3‐98 , 2014, Psycho-oncology.

[37]  S. Linn,et al.  Tamoxifen or letrozole versus standard methods for women with estrogen-receptor positive breast cancer undergoing oocyte or embryo cryopreservation in assisted reproduction. , 2013, The Cochrane database of systematic reviews.

[38]  N. Pavlidis,et al.  Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[39]  K. Oktay,et al.  Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[40]  E. Watson,et al.  Fertility preservation in cancer survivors: a national survey of oncologists' current knowledge, practice and attitudes , 2013, British Journal of Cancer.

[41]  M. Dimopoulos,et al.  Taxanes for breast cancer during pregnancy: a systematic review. , 2013, Clinical breast cancer.

[42]  Pietro Panizza,et al.  The European Society of Breast Cancer Specialists recommendations for the management of young women with breast cancer. , 2012, European journal of cancer.

[43]  T. Fehm,et al.  Treatment of breast cancer during pregnancy: an observational study. , 2012, The Lancet. Oncology.

[44]  P. Katz,et al.  Pretreatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer , 2012, Cancer.

[45]  G. Bepler,et al.  Physician referral for fertility preservation in oncology patients: a national study of practice behaviors. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[46]  C. Anders,et al.  A nationwide survey of oncologists regarding treatment-related infertility and fertility preservation in female cancer patients. , 2007, Fertility and sterility.

[47]  M. Lambertini,et al.  Temporary ovarian suppression during chemotherapy to preserve ovarian function and fertility in breast cancer patients: A GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology. , 2017, European journal of cancer.

[48]  R. Gelber,et al.  Oncology Physicians' Perspectives on Practices and Barriers to Fertility Preservation and the Feasibility of a Prospective Study of Pregnancy After Breast Cancer. , 2017, Journal of adolescent and young adult oncology.

[49]  S. Temin,et al.  Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. , 2016, Journal of oncology practice / American Society of Clinical Oncology.